Free Trial
→ A free stock pick, from me to you (From Behind the Markets) (Ad)tc pixel Free SCLXW Stock Alerts

Scilex (SCLXW) Competitors

Scilex logo
$0.04 0.00 (-4.37%)
As of 11/13/2026 10:40 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

SCLXW vs. SXTPW, ADTX, BFRIW, CINGW, and CMRAW

Should you buy Scilex stock or one of its competitors? Scilex's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Aditxt (ADTX), Biofrontera (BFRIW), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Scilex compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Scilex (NASDAQ:SCLXW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
Scilex$31.61MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.82 beat Scilex's score of 1.79 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Scilex Very Positive

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Scilex N/A N/A N/A

Summary

60 Degrees Pharmaceuticals and Scilex tied by winning 1 of the 2 factors compared between the two stocks.

How does Scilex compare to Aditxt?

Aditxt (NASDAQ:ADTX) and Scilex (NASDAQ:SCLXW) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

In the previous week, Scilex had 1 more articles in the media than Aditxt. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Aditxt. Scilex's average media sentiment score of 1.79 beat Aditxt's score of 0.00 indicating that Scilex is being referred to more favorably in the news media.

Company Overall Sentiment
Aditxt Neutral
Scilex Very Positive

15.5% of Aditxt shares are held by institutional investors. 0.0% of Aditxt shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Scilex has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. Scilex's return on equity of 0.00% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
Aditxt-360,152.50% -374.60% -105.93%
Scilex N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aditxt
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Scilex
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Scilex has higher revenue and earnings than Aditxt.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aditxt$14.34K0.02-$41.71M-$100.79 thousandN/A
Scilex$31.61MN/AN/AN/AN/A

Summary

Scilex beats Aditxt on 6 of the 9 factors compared between the two stocks.

How does Scilex compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Scilex (NASDAQ:SCLXW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

In the previous week, Biofrontera had 2 more articles in the media than Scilex. MarketBeat recorded 3 mentions for Biofrontera and 1 mentions for Scilex. Scilex's average media sentiment score of 1.79 beat Biofrontera's score of 0.93 indicating that Scilex is being referred to more favorably in the news media.

Company Overall Sentiment
Biofrontera Positive
Scilex Very Positive

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Scilex N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Scilex$31.61MN/AN/AN/AN/A

Summary

Biofrontera beats Scilex on 2 of the 3 factors compared between the two stocks.

How does Scilex compare to Cingulate?

Scilex (NASDAQ:SCLXW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

In the previous week, Scilex and Scilex both had 1 articles in the media. Cingulate's average media sentiment score of 1.82 beat Scilex's score of 1.79 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Scilex Very Positive
Cingulate Very Positive

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$31.61MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Summary

Scilex and Cingulate tied by winning 1 of the 2 factors compared between the two stocks.

How does Scilex compare to Comera Life Sciences?

Scilex (NASDAQ:SCLXW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$31.61MN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

In the previous week, Scilex had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Comera Life Sciences. Scilex's average media sentiment score of 1.79 beat Comera Life Sciences' score of 0.00 indicating that Scilex is being referred to more favorably in the media.

Company Overall Sentiment
Scilex Very Positive
Comera Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
Comera Life Sciences N/A N/A N/A

Summary

Scilex beats Comera Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCLXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLXW vs. The Competition

Export
MetricScilexPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$13.80B$7.87B$12.20B
Dividend YieldN/A2.56%2.46%4.53%
P/E RatioN/A29.2934.5630.66
Price / SalesN/A7.338.685.86
Price / CashN/A15.7421.9322.49
Price / BookN/A4.934.353.76
Net IncomeN/A$2.89B$3.52B$390.95M
7 Day PerformanceN/A-0.38%-1.52%-0.34%
1 Month PerformanceN/A-3.22%-3.54%-5.79%
1 Year PerformanceN/A-5.98%1.45%-5.71%

Scilex Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLXW
Scilex
N/A$0.04
-4.4%		N/AN/A$0.00$31.61MN/A34
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
+11.8%		N/AN/A$0.00$1.11MN/A3
ADTX
Aditxt
0.0236 of 5 stars		$0.00
flat		N/AN/A$0.00$14.34KN/A26
BFRIW
Biofrontera
N/A$0.00
flat		N/AN/A$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.00
+97.4%		N/AN/A$0.00N/AN/A14

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SCLXW) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...
Behind the Markets | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel